- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2012 (2012), Article ID 895153, 2 pages
doi:10.1155/2012/895153
Antioxidant Therapies for Neurodegenerative Diseases: Mechanisms, Current Trends, and Perspectives
1Department of Biochemistry, Center for Oxidative Stress Research, Federal University of Rio Grande do Sul (UFRGS), 90035-003 Porto Alegre, RS, Brazil
2Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, L85 4K1, Canada
3Experimental & Translational Respiratory Group, University of Newcastle, Newsastle, NSW 2308, Australia
4Department of Biochemistry, Center for Free Radical and Biomedical Research, School of Medicine, Universidad de la República, 11800 Montevideo, Uruguay
Received 7 November 2012; Accepted 7 November 2012
Copyright © 2012 Daniel Pens Gelain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Daniel Pens Gelain, Guilherme Antonio Behr, Ramatis Birnfeld de Oliveira, and Madia Trujillo, “Antioxidant Therapies for Neurodegenerative Diseases: Mechanisms, Current Trends, and Perspectives,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 895153, 2 pages, 2012. doi:10.1155/2012/895153